Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Analysis of Baseline Factors

被引：0
|
作者：
Nicholas, A.
Singer, C.
Zhang, I.
Pappert, E.
Navia, B.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
426
引用
收藏
页码：S188 / S189
页数：2
相关论文
共 50 条
  • [21] Indirect Comparison of Apomorphine Sublingual Film Versus Levodopa Inhalation Powder for "OFF" Episodes in Parkinson's Disease
    Thach, A.
    Zichlin, M.
    Kirson, N.
    Yang, K.
    Gaburo, K.
    Pappert, E.
    Mehta, D.
    Williams, G.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S197 - S197
  • [22] Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Incremental Motor Improvement Observed with Increasing Doses
    Isaacson, S.
    Zhang, I.
    Pappert, E.
    Bowling, A.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S334 - S335
  • [23] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Characterization of Acute Nausea During Dose Titration
    Ondo, W.
    Hauser, R.
    Bowling, A.
    Isaacson, S.
    Pappert, E.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S189 - S189
  • [24] Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?
    Hauser, Robert A.
    Ondo, William G.
    Zhang, Yi
    Bowling, Alyssa
    Navia, Bradford
    Pappert, Eric
    Isaacson, Stuart H.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2023, 13 (03) : 403 - 414
  • [25] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    [J]. NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [26] Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes
    Thach, A.
    Kirson, N.
    Zichlin, M.
    Dieye, I.
    Pappert, E.
    Williams, G.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S427 - S427
  • [27] Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Impact on Dyskinesia
    Klos, K.
    Hui, J.
    Robottom, B.
    Bhargava, P.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S404 - S404
  • [28] Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson's Disease and "OFF" Episodes: A Pooled Analysis
    Ondo, W.
    Ellenbogen, A.
    Isaacson, S.
    Espay, A.
    Singer, C.
    Bhargava, P.
    Worden, M.
    Blum, D.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2019, 34
  • [29] Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study
    Stocchi, Fabrizio
    Rascol, Olivier
    Poewe, Werner
    Chaudhuri, K. Ray
    Kassubek, Jan
    Lopez Manzanares, Lydia
    Zhang, Yi
    Bowling, Alyssa
    Pappert, Eric
    Wu, Stacy
    [J]. JOURNAL OF PARKINSONS DISEASE, 2023, 13 (08) : 1329 - 1342
  • [30] Apomorphine sublingual film versus subcutaneous apomorphine in the treatment of OFF episodes in Parkinson's disease: results from an assessment of patient satisfaction
    Schwarz, J.
    Carroll, C.
    Ebersbach, G.
    Kulisevsky, J.
    Tessitore, A.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    Thach, A.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S352 - S352
12345